HLAVNÍ TÉMA Novinky v primárních imunodeficitech | 157 / Vnitř Lék. 2026;72(3):151-157 / VNITŘNÍ LÉKAŘSTVÍ www.casopisvnitrnilekarstvi.cz PROHLÁŠENÍ AUTORŮ: Prohlášení o původnosti: Publikace byla zpracována s využitím uvedené literatury a nebyla publikována ani zaslána k recenznímu řízení do jiného média. Střet zájmů: Žádný. Financování: Vznik článku byl podpořen granty NU23-05-00097 a NW26-05-00027 udělenými Ministerstvem zdravotnictví ČR. Registrace v databázích: N/A. Projednání etickou komisí: N/A. LITERATURA 1. Bousfiha AA, Jeddane L, Moundir A, et al. The 2024 update of IUIS phenotypic classification of human inborn errors of immunity. Journal of Human Immunity [Internet]. 2025 May 5 [cited 2025 Apr 23];1(1). Available from: http://dx.doi.org/10.70962/jhi.20250002. 2. Tangye SG, Al-Herz W, Bousfiha A, et al. Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol [Internet]. 2022 Jun 24; Available from: http://dx.doi. org/10.1007/s10875-022-01289-3. 3. Stewart O, Gruber C, Randolph HE, et al. Monoallelic expression can govern penetrance of inborn errors of immunity. Nature. 2025 Jan 1;1-12. 4. Bastard P, Gervais A, Le Voyer T, et al. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Sci Immunol. 2021 Aug 19;6(62):eabl4340. 5. Gervais A, Rovida F, Avanzini MA, et al. Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in ~40% of patients. J Exp Med. [Internet]. 2023 Sep 4;220(9). Available from: http://dx.doi.org/10.1084/jem.20230661 6. Griffin H, Ceron-Gutierrez L, Gharahdaghi N, et al. Neutralizing autoantibodies against interleukin-10 in inflammatory bowel disease. N Engl J Med. 2024 Aug 1;391(5):434-41. 7. Bloomfield M, Hlaváčková E, Schneiderová H, et al. Beyond TREC: Pivotal role of tandem TREC/KREC assay in Czech SCID NBS pilot programme. Pediatr Allergy Immunol. 2025 May 1;36(5):e70100. 8. Poli MC, Aksentijevich I, Bousfiha AA, et al. Human inborn errors of immunity: 2024 update on the classification from the International Union of Immunological Societies Expert Committee. J Hum Immun. 2025 May 5;1(1):e20250003. 9. Bravo García-Morato M, Aracil Santos FJ, Briones AC, et al. New human combined immunodeficiency caused by interferon regulatory factor 4 (IRF4) deficiency inherited by uniparental isodisomy. J Allergy Clin Immunol. 2018 May 1;141(5):1924-1927.e18. 10. Sharma M, Leung D, Momenilandi M, et al. Human germline heterozygous gain-of-function STAT6 variants cause severe allergic disease. J Exp Med [Internet]. 2023 May 1 [cited 2026 Jan 24];220(5). Available from: http://dx.doi.org/10.1084/jem.20221755 11. Brown GJ, Cañete PF, Wang H, et al. TLR7 gain-of-function genetic variation causes human lupus. Nature. 2022 May;605(7909):349-56. 12. David C, Badonyi M, Kechiche R et al. Interface gain-of-function mutations in TLR7 cause systemic and neuro-inflammatory disease. J Clin Immunol. 2024 Feb 7;44(2):60. 13. Moriya K, Nakano T, Honda Y, et al. Human RELA dominant-negative mutations underlie type I interferonopathy with autoinflammation and autoimmunity. J Exp Med [Internet]. 2023 Sep 4;220(9). Available from: http://dx.doi.org/10.1084/jem.20212276. 14. Verdura E, Rodríguez-Palmero A, Vélez-Santamaria V, et al. Biallelic PI4KA variants cause a novel neurodevelopmental syndrome with hypomyelinating leukodystrophy. Brain. 2021 Oct 22;144(9):2659–69. 15. Neehus A-L, Carey B, Landekic M, et al. Human inherited CCR2 deficiency underlies progressive polycystic lung disease. Cell. 2024 Jun 20;187(13):3460. 16. Beck DB, Ferrada MA, Sikora KA, et al. Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease. N Engl J Med. 2020 Dec 31;383(27):2628-38. 17. Sychrovská T, Stibůrková B, Pavelcová K, Mann H. Diagnostic performance of four proposed algorithms for suspected VEXAS syndrome. Rheumatology (Oxford). 2025 Dec 1;64(12):6420-1. 18. Lee D, Le Pen J, Yatim A, et al. Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children. Science. 2023 Feb 10;379(6632):eabo3627. 19. Henderson LA, Abraham RS, Ahmed A, et al. Multidisciplinary approach to treating complex immune dysregulation disorders: an adaptive model for institutional implementation. Front Immunol. 2025 Mar 7;16:1519955. 20. Yazdanpanah N, Rezaei N. The multidisciplinary approach to diagnosing inborn errors of immunity: a comprehensive review of discipline-based manifestations. Expert Rev Clin Immunol. 2024 Oct;20(10):1237-59. 21. Informace k projektu SYPOVO [Internet]. Ministerstvo zdravotnictví České republiky. 2023 [cited 2026 Jan 13]. Available from: https://mzd.gov.cz/navrh-systemu-komplexni-sdilene-zdravotne-socialni-pece-o-pacienty-se-vzacnymi-onemocnenimi-sypovo/ 22. Analýza současného stavu péče o pacienty se vzácnými onemocněními v ČR [Internet]. Ministerstvo zdravotnictví České republiky. 2024 [cited 2026 Jan 13]. Available from: https:// mzd.gov.cz/wp-content/uploads/2024/08/Analyticka-zprava_OBECNA-cast_SYPOVO-1.pdf 23. Czech Republic JARDIN participating country [Internet]. JARDIN Joint Action. JARDIN- -ERN; 2024 [cited 2026 Jan 13]. Available from: https://jardin-ern.eu/country/czech-republic/ 24. Blom M, Soomann M, Soler-Palacín P, et al. Newborn screening for SCID and severe T lymphocytopenia in Europe. J Allergy Clin Immunol [Internet]. 2024 Nov 6 [cited 2025 Jan 8]; Available from: http://dx.doi.org/10.1016/j.jaci.2024. 10. 018. 25. Klocperk A, Bloomfield M, Schneiderová H, et al. Neonatal screening of severe combined immunodeficiency (SCID) in the Czech Republic. Alergie. 2024 Jan 6;2024(2):85-9. 26. Strand J, Gul KA, Erichsen HC, et al. Second-Tier Next Generation Sequencing Integrated in Nationwide Newborn Screening Provides Rapid Molecular Diagnostics of Severe Combined Immunodeficiency. Front Immunol. 2020 Jul 9;11:1417. 27. Blom M, Duintjer AJ, Pico-Knijnenburg I, et al. Next-generation sequencing and other second tier tests in newborn screening for (X-linked) agammaglobulinemia. J Clin Immunol. 2025 Nov 8;45(1):154. 28. Thakar MS, Logan BR, Puck JM, et al. Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium. Lancet. 2023 Jul 8;402(10396):129-40. 29. Booth C, Masiuk K, Vazouras K, et al. Long-term safety and efficacy of gene therapy for adenosine deaminase deficiency. N Engl J Med. 2025 Oct 16;393(15):1486-97. 30. Vladyka O, Simonová AK, Orlický M, et al. Advances in the management of patients with defects of thymic development. Alergie [Internet]. 2025;2025(4). Available from: https:// www.tigis.cz/images/stories/Alergie/Alergie_2025/Alergie_4_2025/Alergie_4_2025_Vladyka_prehledny.pdf 31. Kreins AY, Dhalla F, Flinn AM, et al. European Society for Immunodeficiencies guidelines for the management of patients with congenital athymia. J Allergy Clin Immunol. 2024 Dec 18;154(6):1391-408. 32. Golwala ZM, Goncalves HS, Moirangthem RD, et al. Ex vivo T-lymphopoiesis assays assisting corrective treatment choice for genetically undefined T-lymphocytopaenia. Clin Immunol. 2025 Feb 16;274(110453):110453. 33. Bosticardo M, Pala F, Calzoni E, et al. Artificial thymic organoids represent a reliable tool to study T-cell differentiation in patients with severe T-cell lymphopenia. Blood Adv. 2020 Jun 23;4(12):2611-6. 34. Blom M, Duintjer AJ, Jamee M, de Gier M, Bloomfield M, Klocperk A, et al. Self-reported clinical outcomes and quality of life in agammaglobulinemia: The importance of an early diagnosis. J Clin Immunol. 2025 Aug 25;45(1):125. 35. Messelink MA, Berbers RM, van Montfrans JM, et al. Development of a primary care screening algorithm for the early detection of patients at risk of primary antibody deficiency. Allergy Asthma Clin Immunol. 2023 May 27;19(1):44. 36. Johnson R, Stephens AV, Mester R, et al. Electronic health record signatures identify undiagnosed patients with common variable immunodeficiency disease. Sci Transl Med. 2024 May;16(745):eade4510. 37. Rider NL, Coffey M, Kurian A, et al. A validated artificial intelligence-based pipeline for population-wide primary immunodeficiency screening. J Allergy Clin Immunol. 2023 Jan;151(1):272-9. 38. Rivière JG, Carot-Sans G, Piera-Jiménez J, de la Torre S, PIDCAP expert group, Cos X, et al. Development of an expert-based scoring system for early identification of patients with inborn errors of immunity in primary care settings – the PIDCAP project. J Clin Immunol. 2024 Oct 21;45(1):26. 39. Soler-Palacín P, Rivière JG, Burns SO, Rider NL. New tools for diagnosis of primary immunodeficiencies: from awareness to artificial intelligence. Front Immunol. 2025 Jul 10;16(1593897):1593897. 40. Rider NL, Li Y, Chin AT, et al. Evaluating large language model performance to support the diagnosis and management of patients with primary immune disorders. J Allergy Clin Immunol. 2025 Jul;156(1):81-7. 41. Martin-Geary AC, Lecoquierre F, Walker S, et al. Using SpliceAI to triage splice-altering variants in 7,220 individuals with rare conditions highlights limitations of the precomputed scores [Internet]. medRxiv. 2025. Available from: http://dx.doi.org/10.1101/2 025. 08. 27.25334471. 42. Ameratunga R, Leung EY, Longhurst HJ, et al. Opinion: the evolving understanding of polygenic common variable immunodeficiency-like disorders. Front Immunol. 2025 Aug 28;16(1618482):1618482. Další literatura u autora a na www.casopisvnitrnilekarstvi.cz
RkJQdWJsaXNoZXIy NDA4Mjc=